Nature Biotechnology News Article – After GLP-1, what’s next for weight loss?

The GLP-1 agonist Wegovy has re-energized the hunt for obesity treatments. Alternatives — ranging from bitter taste compounds to lean muscle boosters and bacteria — are already in the clinic.

Download the PDF here